Hybrid closed-loop insulin therapy prevents low night-time blood glucose levels among breastfeeding mothers with type 1 ...

PharmaSens, a developer of insulin patch pumps for people with diabetes, has appointed Robert A. Gabbay, MD, PhD, FACP and James L. Peterson to its board of directors.

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

1 mylife Loop consists of the mylife YpsoPump, a lightweight intuitive insulin pump, integrated with the CamAPS FX hybrid ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

PharmaSens, a developer of innovative insulin patch pumps for people with diabetes, has announced the appointment of Robert A. Gabbay, MD, PhD, FACP and James L. Peterson to its board of directors.

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) HME to patients discharged from acute care and other facilities, ...

Medtronic Inc., the leading maker of insulin pumps, told Medscape Medical News ... but then switched to another method of insulin therapy, the MAUDE report said. It’s unclear how often DST ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because ... unexpectedly stop therapy. Medtronic, which has ...

"According to the latest study from BCC Research "Infusion Pumps and Devices: Technologies and Global Markets," the global market is expected to grow from $10.1 billion in 2024 to $14.7 billion by the ...

"Pumps that have been dropped ... All users should also carry back-up insulin therapy at all times in case of an emergency. This recall does not involve removing all products.